Genzyme was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. From Wikipedia
Securing Ayvakit licensing reinforces Sanofi’s bid to dominate immunology with a focus on rare diseases
